Nicorette Fruktmint (Nicotine Resinate)

• Nicotine resinate is used in nicotine replacement therapy to aid smoking cessation.
• Smoking cessation: assists adult smokers in quitting by alleviating withdrawal symptoms and cravings.
• Relapse prevention: helps maintain abstinence after quitting by providing controlled nicotine exposure.
• Tobacco use reduction: enables a step‑down approach for smokers who wish to gradually lower cigarette consumption.

• Nicotine resinate acts as an agonist at nicotinic acetylcholine receptors in the central nervous system. By stimulating these receptors, it mimics the pharmacological effects of nicotine from tobacco, thereby reducing the intensity of withdrawal symptoms and cravings. This controlled activation allows the user to taper nicotine intake gradually, facilitating cessation of smoking.

Nicotine resinate may cause a range of adverse reactions.

Common Side Effects

• Mouth irritation or soreness
• Nausea or upset stomach
• Dizziness or light‑headedness
• Headache
• Hiccups or throat discomfort
• Insomnia or sleep disturbances

Serious or Rare Side Effects

• Allergic reaction (rash, swelling, difficulty breathing)
• Chest pain or palpitations
• Severe hypertension
• Arrhythmias
• Anaphylaxis (rare)
• Persistent vomiting

Use of nicotine resinate requires careful consideration of certain safety aspects.

• Cardiovascular assessment: patients with recent heart attack or uncontrolled hypertension should consult a physician before use.
• Pregnancy and lactation: discuss potential risks with a healthcare provider; use only if clearly needed.
• Concomitant nicotine products: avoid using other nicotine‑containing items to prevent overdose.
• Duration of therapy: limit use to the recommended period and monitor for dependence.
• Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Nicotine resinate can interact with other medicines, affecting safety and efficacy.

Major Interactions (Avoid)

• Concurrent use of monoamine oxidase inhibitors (MAOIs): may increase risk of hypertensive crisis.
• Use with other nicotine‑containing products (e.g., patches, e‑cigarettes): risk of nicotine toxicity.

Moderate Interactions (Monitor Closely)

• CYP2A6 inhibitors (e.g., cimetidine): may raise nicotine plasma levels.
• Beta‑blockers: nicotine‑induced tachycardia may be masked.
• Alcohol: may enhance nicotine cravings and affect metabolism.
• Certain antipsychotics (e.g., clozapine): nicotine may alter drug clearance.